Dr. John Cole, MD
Claim this profileOchsner Medical Center Jefferson
Studies Breast Cancer
Studies Cancer
11 reported clinical trials
40 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage III
Stage IV
2Cancer
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials John Cole, MD is currently running
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Internet-Based Pain Management Program
for Cancer Survivors
To determine whether an Internet-based pain coping skills program plus enhanced usual care, compared to enhanced usual care alone, yields significant improvements in the co-primary outcomes of pain severity (as measured by the Brief Pain Inventory (BPI)) and pain interference (also measured by the BPI) from baseline to the post-intervention assessment for cancer survivors with persistent pain.
Recruiting1 award N/A17 criteria
More about John Cole, MD
Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments John Cole, MD has experience with
- Paclitaxel
- Cyclophosphamide
- Carboplatin
- Biospecimen Collection
- Nilotinib Hydrochloride Monohydrate
- Pelareorep
Breakdown of trials John Cole, MD has run
Breast Cancer
Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Cole, MD specialize in?
John Cole, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage III.
Is John Cole, MD currently recruiting for clinical trials?
Yes, John Cole, MD is currently recruiting for 4 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that John Cole, MD has studied deeply?
Yes, John Cole, MD has studied treatments such as Paclitaxel, Cyclophosphamide, Carboplatin.
What is the best way to schedule an appointment with John Cole, MD?
Apply for one of the trials that John Cole, MD is conducting.
What is the office address of John Cole, MD?
The office of John Cole, MD is located at: Ochsner Medical Center Jefferson, New Orleans, Louisiana 70121 United States. This is the address for their practice at the Ochsner Medical Center Jefferson.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.